Inflamación y Daño Vascular en la Enfermedad Renal Crónica, Diálisis y Trasplante Renal. Fisiopatología renal

Gorriz, JL; Arroyo, D; D'Marco, L; Torra, R; Tomas, P; Puchades, MJ; Panizo, N; Pantoja, J; Montomoli, M; Llisterri, JL; Pallares-Carratala, V; Valdivielso, JM.

Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant polycystic kidney disease

BMC Nephrology. 2021; 22(1): 110-110 Nº de citas: 6 [doi:10.1186/s12882-021-02313-1]

Zaballos, M; Power, M; Canal-Alonso, MI; Gonzalez-Nicolas, MA; Vasquez-Jimenez, W; Lozano-Lominchar, P; Cabrerizo-Torrente, P; Palencia-Garcia, N; Gago-Quiroga, S; Ginel-Feito, MD; Jimenez, C; Lazaro, A; Gonzalez-Bayon, L.

Effect of Cilastatin on Cisplatin-Induced Nephrotoxicity in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021; 22(3): Nº de citas: 9 [doi:10.3390/ijms22031239]

Pérez de José A; Carbayo, J; Pocurull, A; Bada-Bosch, T; Cases Corona CM; Shabaka, A; Ramos Terrada N; Martinez Valenzuela L; Huerta, A; Fernandez Lorente L; Malek-Marin, TG; Goicoechea, M.

Direct-acting antiviral therapy improves kidney survival in hepatitis C virus-associated cryoglobulinaemia: the RENALCRYOGLOBULINEMIC study

CLINICAL KIDNEY JOURNAL. 2021; 14(2): 586-592 Nº de citas: 11 [doi:10.1093/ckj/sfz178]

Bascunana, A; Mijaylova, A; Vega, A; Macias, N; Verde, E; Rodriguez-Ferrero, ML; Delgado, A; Carbayo, J; Goicoechea, M.

Thrombotic Microanalopathy in a Kidney Transplant Patient with COVID-19

Kidney Medicine. 2021; 3(1): 124-127 Nº de citas: 9 [doi:10.1016/j.xkme.2020.09.014]

Villacorta, J; Lucientes, L; Goicoechea, E; Acevedo, M; Cavero, T; Sanchez-Camara, L; Diaz-Crespo, F; Gimenez-Moyano, S; Garcia-Bermejo, L; Fernandez-Juarez, G.

Urinary soluble CD163 as a biomarker of disease activity and relapse in antineutrophil cytoplasm antibody-associated glomerulonephritis

CLINICAL KIDNEY JOURNAL. 2021; 14(1): 212-219 Nº de citas: 11 [doi:10.1093/ckj/sfaa043]

Galar, A; Valerio, M; Catalan, P; Garcia-Gonzalez, X; Burillo, A; Fernandez-Cruz, A; Zatarain, E; Sousa-Casasnovas, I; Anaya, F; Rodriguez-Ferrero, ML; Munoz, P; Bouza, E.

Valganciclovir-Ganciclovir Use and Systematic Therapeutic Drug Monitoring. An Invitation to Antiviral Stewardship

Antibiotics-Basel. 2021; 10(1): Nº de citas: 25 [doi:10.3390/antibiotics10010077]

Torres, E; Aragoncillo, I; Moreno, J; Vega, A; Abad, S; Garcia-Prieto, A; Macias, N; Hernandez, A; Godino, MT; Luno, J.

Exercise training during hemodialysis sessions: Physical and biochemical benefits

THERAPEUTIC APHERESIS AND DIALYSIS. 2020; 24(6): 648-654 Nº de citas: 11 [doi:10.1111/1744-9987.13469]

Perez-Saez, MJ; Blasco, M; Redondo-Pachon, D; Ventura-Aguiar, P; Bada-Bosch, T; Perez-Flores, I; Melilli, E; Sanchez-Camara, LA; Lopez-Oliva, MO; Canal, C; Shabaka, A; Garra-Moncau, N; Martin-Moreno, PL; Lopez, V; Hernandez-Gallego, R; Siverio, O; Galeano, C; Espi-Reig, J; Cabezas, CJ; Rodrigo, MT; Llinas-Mallol, L; Fernandez-Reyes, MJ; Cruzado-Vega, L; Perez-Tamajon, L; Santana-Estupinan, R; Ruiz-Fuentes, MC; Tabernero, G; Zarraga, S; Ruiz, JC; Gutierrez-Dalmau, A; Mazuecos, A; Sanchez-Alvarez, E; Crespo, M; Pascual, J; Spanish Soc Nephrology COVID-19 Gr.

Use of tocilizumab in kidney transplant recipients with COVID-19

AMERICAN JOURNAL OF TRANSPLANTATION. 2020; 20(11): 3182-3190 Nº de citas: 69 [doi:10.1111/ajt.16192]

Caravaca-Fontan, F; Diaz-Encarnacion, MM; Lucientes, L; Cavero, T; Cabello, V; Ariceta, G; Quintana, LF; Marco, H; Barros, X; Ramos, N; Rodriguez-Mendiola, N; Cruz, S; Fernandez-Juarez, G; Rodriguez, A; de Jose, AP; Rabasco, C; Rodado, R; Fernandez, L; Gomez, VP; Avila, AI; Bravo, L; Lumbreras, J; Allende, N; de la Nieta, MDS; Rodriguez, E; Olea, T; Melgosa, M; Huerta, A; Miquel, R; Mon, C; Fraga, G; de Lorenzo, A; Draibe, J; Cano-Megias, M; Gonzalez, F; Shabaka, A; Lopez-Rubio, ME; Fenollosa, MA; Martin-Penagos, L; Da Silva, I; Titos, JA; de Cordoba, SR; de Jorge, EG; Praga, M.

Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the Disease

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2020; 15(9): 1287-1298 Nº de citas: 48 [doi:10.2215/CJN.15241219]

Jado, JC; Humanes, B; Gonzalez-Nicolas, MA; Camaño S; Lara, JM; Lopez, B; Cercenado, E; Garcia-Bordas, J; Tejedor, A; Lazaro, A.

Nephroprotective Effect of Cilastatin against Gentamicin-Induced Renal Injury In Vitro and In Vivo without Altering Its Bactericidal Efficiency

Antioxidants. 2020; 9(9): Nº de citas: 26 [doi:10.3390/antiox9090821]

Palacios-Mendoza, MA; Gines, MLM; Otalora, PJM; Cuello, JP; Sanchez-Soblechero, A; Ros, AL; Aparcero-Suero, JA; Anguita, SL; Anaya, F; Dominguez, JMG.

Plasma exchange in acute attacks of demyelinating diseases of the central nervous system: clinical outcomes and predictors of response

NEUROLOGICAL SCIENCES. 2020; 41(9): 2569-2574 Nº de citas: 5 [doi:10.1007/s10072-020-04382-w]

Garcia-Prieto, AM; Verdalles, U; de Jose, AP; Verde, E; Arroyo, D; Aragoncillo, I; Linares, T; Barbieri, D; Goicoechea, M.

The effect of renin-angiotensin-aldosterone system blockers on the progression of chronic kidney disease in hypertensive elderly patients without proteinuria: PROERCAN study. Rationale and design

Hipertension y Riesgo Vascular. 2020; 37(3): 101-107 [doi:10.1016/j.hipert.2020.02.005]

Cedeno, S; Vega, A; Macias, N; Sanchez, L; Abad, S; Lopez-Gomez, JM; Luno, J.

Intradialytic hypotension definitions with mortality prediction capacity in a cohort of haemodialysis patients

NEFROLOGIA. 2020; 40(4): 403-413 Nº de citas: 10 [doi:10.1016/j.nefro.2020.01.003]

Bermejo, S; Gonzalez, E; Lopez-Revuelta, K; Ibernon, M; Lopez, D; Martin-Gomez, A; Garcia-Osuna, R; Linares, T; Diaz, M; Martin, N; Barros, X; Marco, H; Navarro, MI; Esparza, N; Elias, S; Coloma, A; Robles, NR; Agraz, I; Poch, E; Rodas, L; Lozano, V; Fernandez, B; Hernandez, E; Martinez, MI; Stanescu, RI; Moiron, JP; Garcia, N; Goicoechea, M; Calero, F; Bonet, J; Galceran, JM; Liano, F; Pascual, J; Praga, M; Fulladosa, X; Soler, MJ.

Risk factors for non-diabetic renal disease in diabetic patients

CLINICAL KIDNEY JOURNAL. 2020; 13(3): 380-388 Nº de citas: 28 [doi:10.1093/ckj/sfz177]

Tejedor, A.

The heart and kidney in diabetes: Heart and kidney in diabetes

Hipertension y Riesgo Vascular. 2020; 37(2): 64-71 Nº de citas: 1 [doi:10.1016/j.hipert.2020.02.002]

Vega, A; Sanchez-Nino, MD; Ortiz, A; Abad, S; Macias, N; Aragoncillo, I; Santos, A; Garcia-Prieto, A; Torres, E; Hernandez, A; Sanchez-Camara, L; Hurtado, E; Valino-Rivas, L; Luno, J.

The new marker YKL-40, a molecule related to inflammation, is associated with cardiovascular events in stable haemodialysis patients

CLINICAL KIDNEY JOURNAL. 2020; 13(2): 172-178 Nº de citas: 8 [doi:10.1093/ckj/sfz056]

Vink, P; Torrell, JMR; Fructuoso, AS; Kim, SJ; Kim, SI; Zaltzman, J; Ortiz, F; Plana, JMC; Rodriguez, AMF; Rodrigo, HR; Marti, MC; Perez, R; Roncero, FMG; Kumar, D; Chiang, YJ; Doucette, K; Pipeleers, L; Morales, MLA; Rodriguez-Ferrero, ML; Secchi, A; McNeil, SA; Campora, L; Di Paolo, E; El Idrissi, M; Lopez-Fauqued, M; Salaun, B; Heineman, TC; Oostvogels, L; Rossana, C; Mario, C; Yen-Ta, C; Giacomo, G; Esther, GM; Nada, K; Dirk, K; Cheng-Chia, L; Umberto, M; Pavel, N; Arjan, V; Ignacio, VNJ; Bice, V; Ming-Ju, W; Z-041 Study Grp.

Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: A Phase 3, Randomized Clinical Trial

CLINICAL INFECTIOUS DISEASES. 2020; 70(2): 181-190 Nº de citas: 153 [doi:10.1093/cid/ciz177]

Verdalles, U; Goicoechea, M; de Vinuesa, SG; Torres, E; Hernandez, A; Verde, E; de Jose, AP; Luno, J.

Chronic kidney disease progression in patients with resistant hypertension subject to 2 therapeutic strategies: Intensification with loop diuretics vs aldosterone antagonists

NEFROLOGIA. 2020; 40(1): 65-73 Nº de citas: 2 [doi:10.1016/j.nefro.2019.04.012]